Compare WMG & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WMG | ARWR |
|---|---|---|
| Founded | 1929 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.2B | 12.4B |
| IPO Year | 2005 | 2009 |
| Metric | WMG | ARWR |
|---|---|---|
| Price | $27.22 | $66.03 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 10 |
| Target Price | $36.38 | ★ $83.40 |
| AVG Volume (30 Days) | 1.6M | ★ 1.9M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.72% | N/A |
| EPS Growth | N/A | ★ 99.80 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $4,463,000,000.00 | $16,142,321.00 |
| Revenue This Year | $7.20 | N/A |
| Revenue Next Year | $5.99 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $23.34 | $33.02 |
| 52 Week High | $35.42 | $95.49 |
| Indicator | WMG | ARWR |
|---|---|---|
| Relative Strength Index (RSI) | 44.22 | 31.23 |
| Support Level | $26.56 | $61.25 |
| Resistance Level | $29.73 | $66.37 |
| Average True Range (ATR) | 0.77 | 4.29 |
| MACD | -0.18 | -1.16 |
| Stochastic Oscillator | 12.82 | 6.91 |
Warner Music is the third-largest of the three major record companies. Recorded music accounts for most of the firm's revenue, with the segment housing notable record labels including Atlantic Records, Warner Records, Elektra Records. Some of the most successful current artists signed to record deals with Warner include Ed Sheeran, Bruno Mars, Cardi B, and Dua Lipa. Warner's remaining revenue comes from its publishing business, where Warner Chappell represents more than 180,000 songwriters and composers, some of whom are also Warner recording artists but many of whom are not recording artists or are attached to other labels. Warner Chappell controls more than 1 million musical compositions. Access Industries controls 98% of Warner's voting rights, while holding a 72% economic interest.
Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body.